A defective, rearranged Epstein-Barr virus genome in EBER-negative and EBER-positive Hodgkin's disease

American Journal of Pathology

Volumn 160, Issue 3, 2002, Pages 781-786

  Gan, Yan Jun ^a   Razzouk, Bassem I ^b   Su, Tao ^a   Sixbey, John W ^a  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA; VIRUS RNA;

ADENYLATION; ARTICLE; BURKITT LYMPHOMA; CHILD; CONTROLLED STUDY; EPSTEIN BARR VIRUS; GENE AMPLIFICATION; GENE CONTROL; GENE SEQUENCE; GENETIC ANALYSIS; HODGKIN DISEASE; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; INFECTIOUS MONONUCLEOSIS; LEUKOPLAKIA; MAJOR CLINICAL STUDY; NASOPHARYNX CARCINOMA; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TUMOR CELL; VIRUS GENE;

EID: 0036124507     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)64900-0     Document Type: Article

References (45)

1. Disappearance of the Epstein-Barr virus in a relapse of Hodgkin's disease
2. Discrepancies in Epstein-Barr virus association at presentation and relapse of classical Hodgkin's disease: Impact on pathogenesis
3. Epstein-Barr virus DNA recombination and loss in sporadic Burkitt's lymphoma
4. Spontaneous loss of viral episomes accompanying Epstein-Barr virus reactivation in a Burkitt's lymphoma cell line
5. P3HR-1 Epstein-Barr virus with heterogeneous DNA is an independent replicon maintained by cell-to-cell spread
6. Identification of a rare Epstein-Barr virus variant that enhances early antigen expression in Raji cells
7. Detection of EBV gene expression in Reed-Sternberg cells of Hodgkin's Disease
8. Epstein-Barr virus in pediatric Hodgkin disease: Age and histiotype are more predictive than geographic region
9. Sample preparation from paraffin-embedded tissues
10. Polymorphisms of the region of the Epstein-Barr virus genome which disrupts latency
11. Defective viral DNA in Epstein-Barr virus-associated oral hairy leukoplakia
12. Polymerase chain reaction in situ: Intracellular amplification and detection of HIV-1 proviral DNA and other specific genes
13. Infusion of cytotoxic T cells for the prevention and treatment of Epstein-Barr virus-induced lymphoma in allogeneic transplant recipients
14. Normalized quantification of Epstein-Barr virus load by means of real-time PCR in patients at risk for posttransplant lymphoproliferative disorder
15. Association between clinical disease activity and Epstein-Barr virus reactivation in MS
16. Structure of defective DNA molecules in Epstein-Barr virus preparations from P3HR-1 cells
17. Epstein-Barr virus (P3HR-1) defective DNA codes for components of both the early antigen and viral capsid antigen complexes
18. Epstein-Barr virus DNA is abundant and monoclonal in the Reed-Sternberg cells of Hodgkin's disease: Association with mixed cellularity subtype and Hispanic American ethnicity
19. Detection of Epstein-Barr viral genomes in Reed-Sternberg cells of Hodgkin's disease
20. Detection of Epstein-Barr virus in Hodgkin-Reed-Sternberg cells: No evidence for the persistence of integrated viral fragments in latent membrane protein-1 (LMP-1)-negative classical Hodgkin's disease
21. Gammaherpesviruses and 'hit-and-run' oncogenesis
22. Detection of Epstein-Barr virus genomes in Hodgkin's disease: Relation to age
23. Epstein-Barr virus-associated Hodgkin's Disease: Epidemiologic characteristics in international data
24. Epstein-Barr virus DNA IX: Variation among viral DNAs from producer and nonproducer infected cells
25. Heterogeneity of Epstein-Barr virus. III. Comparison of a transforming and a nontransforming virus by partial denaturation mapping of their DNAs
26. Palindromic structure and polypeptide expression of 36 kilobase-pairs of heterogeneous Epstein-Barr virus (P3HR-1) DNA
27. Sequences of the Epstein-Barr virus (EBV) large internal repeat form the center of a 16-kilobase-pair palindrome of EBV (P3HR-1) heterogeneous DNA
28. Epstein-Barr virus and its replication
29. Genomic rearrangements activate the Epstein-Barr virus gene whose product disrupts latency
30. Partial elimination of Epstein-Barr virus plasmids from Burkitt's lymphoma cells by transfection of the BZLF1 gene
31. The Epstein-Barr virus latency BamHI-Q promoter is positively regulated by STATs and Zta interference with JAK/STAT activation leads to loss of BamHI-Q promoter activity
32. Activation of Epstein-Barr virus replication in Hodgkin and Reed-Sternberg cells
33. Epstein-Barr virus replication in Hodgkin's disease
34. Expression of the Epstein-Barr virus latent membrane protein 1 induces B cell lymphoma in transgenic mice
35. Epstein-Barr virus LMP2A transforms epithelial cells, inhibits cell differentiation, and activates Akt
36. Isolation of Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes that lyse Reed-Sternberg cells: Implications for immune-mediated therapy of EBV+ Hodgkin's disease
37. Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes for the treatment of patients with EBV-positive relapsed Hodgkin's disease
38. Description of an in situ hybridization methodology for detection of Epstein-Barr virus RNA in paraffin-embedded tissues, with a survey of normal and neoplastic tissues
39. Epstein-Barr virus small nuclear RNAs are not expressed in permissively infected cells in AIDS-associated leukoplakia
40. Detection of Epstein-Barr virus (EBV) in hepatocellular carcinoma tissue: A novel EBV latency characterized by the absence of EBV-encoded small RNA expression
41. Expression of the Epstein-Barr virus BamHI A fragment in nasopharyngeal carcinoma: Evidence for a viral protein expressed in vivo
42. Transcription of BamHI A region of the EBV genome in NPC tissues and B cells
43. Structural analysis of the Epstein-Barr virus BamHI A transcripts
44. Structure and coding content of CST (BART) family of RNAs of Epstein-Barr virus